Xanthoangelol and 4-Hydroxyderricin Are the Major Active Principles of the Inhibitory Activities against Monoamine Oxidases on Angelica keiskei K |
Kim, Ji Ho
(Daewoong Co., Ltd.)
Son, Yeon Kyung (Daewoong Co., Ltd.) Kim, Gun Hee (Plant Resources Research Institute, Duksung Women's University) Hwang, Keum Hee (Plant Resources Research Institute, Duksung Women's University) |
1 | Lotufo-Neto, F., Trivedi, M. and Thase, M. E. (1999) Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofarnmine for the treatment of depression. Neuropsychopharmacology 20, 226-247. DOI ScienceOn |
2 | Mann, J. J., Aarons. S. F., Wilner, P. J., Keilp, J. G., Sweeney, J. A., Pearlstein, T., Frances, A. J., Kocsis, J. H. and Brown, R. P. (1989) A controlled study of the antidepressant effi cacy and side effects of (-) deprenyl. A selective monoamine oxidase inhibitor. Arch. Gen. Psychiatry 46, 45-50. DOI |
3 | Meyer, J. H., Wilson, A. A., Sagrati, S., Miler, L., Rusjan, P., Bloomfi eld, P. M., Clark, M., Sacher, J., Voineskos, A. N. and Houle, S. (2009) Brain monoamine oxidase a binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. Arch. Gen. Psychiatry 66, 1304-1312. DOI ScienceOn |
4 | Ogawa, H., Ohno, M. and Baba, K. (2005) Hypotensive and lipidregulatory actions of 4-hydroxyderricin, a chalcone from Angelca keiskea, in stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 32, 19-23. DOI ScienceOn |
5 | Okuyama, T., Takata, M., Takayasu, J., Hasegawa, T., Tokuda, H., Nishino, A., Nishino, H. and Iwahima, A. (1991) Anti-tumor-promotion by principles obtained from Angelica keiskei. Planta Med. 57, 242-246. DOI ScienceOn |
6 | Park, J. C., Cho, Y. S., Park, S. K., Park, J. R., Chun, S. S., Ok, K. D. and Choi, J. W. (1995) Isolation of fl avone-7-O-glycosides from the aerial parts of Anglica keiskei and anti-hyperlipidmic effect. Korean J. Pharmacogn. 26, 337-343. |
7 | Park, J. R., Park, S. K., Cho, Y. S., Chun, S. S., Choi, S. H. and Park J. C. (1997) Effects of Angelica keiskei on lipid metabolism in rats. J. Korean Soc. Food Sci. Nutr. 26, 308-313. 과학기술학회마을 |
8 | Quitkin, F., Rifkin, A. and Klein, D. F. (1979) Monoamine oxidase inhibitors: a review of antidepressant effectiveness. Arch. Gen. Psychiatry 36, 749-760. DOI ScienceOn |
9 | Riederer, P., Reynolds, G. P., Jellinger, K., Seemann, D. and Danielczyk, W. (1983). Tranylcypromine isomers in Parkinson's disease: effect of low doses on monoamine oxidase inhibition and blood pressure response. Mod. Probl. Pharmacopsychiatry 19, 154-161. |
10 | Rigal, F. and Zarifi an, E. (1983) MAO inhibitors in psychiatric therapy: effects and side effects. Mod. Probl. Pharmacopsychiatry 19, 162-169. |
11 | Shimizu, E., Hayashi, A., Takahashi, R., Aoyagi, Y., Murakami, T. and Kimoto, K. (1999) Effects of angiotensin I-converting enzyme inhibitor from Ashitaba (Angelica keiskei) on blood pressure of spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. 45, 375-383. DOI |
12 | Stern, G. M., Lees, A. J., Hardie, R. and Sandler, M. (1983) Clinical and pharmacological aspects of (-)-deprenyl treatment in Parkinson's disease. Acta Neurol. Scand. Suppl. 95, 113-116. |
13 | Wimbiscus, M., Kostenko, O. and Malone, D. (2010) MAO inhibitors: Risks, benefi ts, and lore. Cleve. Clin. J. Med. 77, 859-882. DOI ScienceOn |
14 | Akihisa, T., Tokuda, H., Hasegawa, D., Ukiya, M., Kimura, Y., Enjo, F., Suzuki, T. and Nishino, H. (2003) Chalcones, coumarins, and fl avanones from the exudate of Angelica keiskei and their chemopreventive effects. Cancer Lett. 201, 133-137. DOI ScienceOn |
15 | Han, Y. N., Choo, Y. S., Lee, Y. C., Moon, Y. I., Kim, S. D. and Choi, J. W. (2001) Monoamine oxidase B inhibitors from the fruits of Opuntia fi cus-indica var. saboten. Arch. Pharm. Res. 24, 51-54. DOI ScienceOn |
16 | Baba, K., Nakata, K., Taniguchi, M., Kido, T. and Kozawa, M. (1990) Chalcones from Angelica keiskei. Phytochemistry 29, 3907-3910. DOI ScienceOn |
17 | Birkmayer, W., Knoll, J., Riederer, P. and Youdim, M. (1983) (-)-Deprenyl leads to prolongation of L-dopa effi cacy in Parkinson's disease. Mod. Probl. Pharmacopsychiatry 19, 170-176. |
18 | Fujita, T., Sakuma, S., Sumiya, T., Nishida, H., Fujimoto, Y., Baba, K. and Kozawa, M. (1992) The effects of xanthoangelol E on arachidonic acid metabolism in the gastric antral mucosa and platelet of the rabbit. Res. Comun. Chem. Pathol. Pharmacol. 77, 227-240. |
19 | Kim, O. K., Kung, S. S., Park, W. B., Lee, M. W. and Ham, S. S. (1992) The nutritional components of aerial whole plant and juice of Angelica keiskei. Korean J. Food Sci. Technol. 25, 592-596. 과학기술학회마을 |
20 | Kim, J. H., Kim, G. H. and Hwang K. H. (2012) Monoamine oxadase and dopamine -hydroxylase inhibitors from the fruits of gardenia jasminoides. Biomol. Ther. 20, 214-219. DOI ScienceOn |
21 | Kitaichi, Y., Inoue, T., Nakagawa, S., Boku, S., Izumi, T. and Koyama, T. (2010) Combined treatment with MAO-A inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in -phenylethylamine. Euro. J. Pharmacol. 637, 77-82. DOI ScienceOn |
22 | Larsen, J. K., Gjerris, A. P., Anderson. J., Bille, A., Christensen, E. M., Hoyer, E., Hensen, H., Mejlhede, A., Langagergaard, A., Laursen, A. L., Nilkantan, B., Olafsson, K., Severin, B. and Rafaelsen, O. J. (1991) Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasing atypical depression. Acta Psychiatr. Scand. 84, 564-570. DOI ScienceOn |
23 | Lipper, S., Murphy, D. L., Slater, S. and Buchsbaum, M. S. (1979) Comparative behavioral effects of clorgyline and pargyline in man: a preliminart evaluation. Psychopharmacol. (Berl) 62, 123-128. DOI |